Reinhart Partners LLC. Purchases 1,127,346 Shares of Maximus, Inc. $MMS

Reinhart Partners LLC. grew its holdings in Maximus, Inc. (NYSE:MMS) by 131.8% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,982,415 shares of the health services provider’s stock after acquiring an additional 1,127,346 shares during the quarter. Maximus accounts for about 2.4% of Reinhart Partners LLC.’s investment portfolio, making the stock its 18th largest holding. Reinhart Partners LLC. owned about 3.77% of Maximus worth $106,575,000 at the end of the most recent quarter.

A number of other large investors have also bought and sold shares of MMS. Farther Finance Advisors LLC increased its position in shares of Maximus by 69.0% during the fourth quarter. Farther Finance Advisors LLC now owns 284 shares of the health services provider’s stock worth $25,000 after acquiring an additional 116 shares in the last quarter. Advisory Services Network LLC bought a new position in Maximus during the 3rd quarter worth about $32,000. Canada Pension Plan Investment Board bought a new position in Maximus during the 2nd quarter worth about $35,000. Northwestern Mutual Wealth Management Co. raised its stake in shares of Maximus by 225.2% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 439 shares of the health services provider’s stock valued at $38,000 after purchasing an additional 304 shares during the period. Finally, Richardson Financial Services Inc. raised its stake in shares of Maximus by 29.6% in the 4th quarter. Richardson Financial Services Inc. now owns 451 shares of the health services provider’s stock valued at $39,000 after purchasing an additional 103 shares during the period. 97.21% of the stock is owned by institutional investors.

Key Maximus News

Here are the key news stories impacting Maximus this week:

• Positive Sentiment: Fiscal Q3 adjusted earnings were $2.22 per share, ahead of analyst estimates of approximately $2.20–$2.21 and up from $2.16 a year earlier. Higher margins also supported the quarter’s bottom-line performance. Maximus Q3 Earnings Beat Estimates, Increase Year Over Year
• Positive Sentiment: The earnings beat, year-over-year EPS growth and stronger margins indicate that Maximus is maintaining profitability even as sales soften. Maximus Q3 Earnings Beat Estimates
• Neutral Sentiment: Management’s fiscal Q3 earnings call focused on the quarterly performance and updated outlook, providing investors with additional context on operating trends and the company’s expectations for the remainder of fiscal 2026. Maximus Q3 2026 Earnings Call Transcript
• Negative Sentiment: Revenue was $1.28 billion, below the $1.33 billion consensus estimate and down 5.1% year over year. The shortfall suggests softer demand or project timing is limiting growth. Maximus Fiscal Q3 Earnings Snapshot
• Negative Sentiment: Maximus reduced fiscal 2026 EPS guidance to $7.90–$8.20, below the consensus estimate of $8.43. Revenue guidance of $5.2–$5.4 billion remains broadly in line with expectations at the midpoint, but the lower profit outlook is a key overhang for MMS. Updated Maximus Fiscal 2026 Guidance

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on MMS shares. Weiss Ratings lowered Maximus from a “hold (c)” rating to a “hold (c-)” rating in a report on Wednesday, May 20th. Zacks Research cut Maximus from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 27th. Finally, Wall Street Zen downgraded Maximus from a “buy” rating to a “hold” rating in a research report on Saturday. Two analysts have rated the stock with a Hold rating, Based on data from MarketBeat, Maximus has an average rating of “Hold”.

Maximus Price Performance

NYSE:MMS opened at $59.21 on Friday. The stock’s 50-day simple moving average is $58.63 and its 200 day simple moving average is $67.46. Maximus, Inc. has a 52-week low of $52.73 and a 52-week high of $100.00. The company has a debt-to-equity ratio of 0.90, a quick ratio of 2.21 and a current ratio of 2.42. The company has a market cap of $3.11 billion, a P/E ratio of 8.75 and a beta of 0.59.

Maximus (NYSE:MMS) last posted its quarterly earnings results on Thursday, August 6th. The health services provider reported $2.22 earnings per share for the quarter, beating analysts’ consensus estimates of $2.21 by $0.01. The firm had revenue of $1.28 billion during the quarter, compared to the consensus estimate of $1.33 billion. Maximus had a return on equity of 24.91% and a net margin of 7.07%.The business’s revenue was down 5.1% compared to the same quarter last year. During the same period last year, the company earned $2.16 earnings per share. Maximus has set its FY 2026 guidance at 7.900-8.200 EPS. As a group, sell-side analysts forecast that Maximus, Inc. will post 8.05 EPS for the current fiscal year.

Maximus Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, August 31st. Investors of record on Friday, August 14th will be issued a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date is Friday, August 14th. Maximus’s payout ratio is presently 19.76%.

Maximus Profile

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.